Free Trial

WCM Investment Management LLC Has $26.11 Million Position in HealthEquity, Inc. $HQY

HealthEquity logo with Medical background

Key Points

  • WCM Investment Management LLC increased its stake in HealthEquity, Inc. by 7.0%, owning 0.29% of the company, valued at approximately $26.11 million.
  • A number of analysts have upgraded their price targets for HealthEquity, with estimates rising to around $134, reflecting optimism about the company's performance following its recent earnings report.
  • HealthEquity's last quarterly earnings showed a revenue of $325.80 million, slightly above analyst estimates, indicating a solid financial performance.
  • MarketBeat previews top five stocks to own in November.

WCM Investment Management LLC boosted its position in shares of HealthEquity, Inc. (NASDAQ:HQY - Free Report) by 7.0% in the second quarter, according to the company in its most recent disclosure with the SEC. The firm owned 248,950 shares of the company's stock after purchasing an additional 16,309 shares during the quarter. WCM Investment Management LLC owned 0.29% of HealthEquity worth $26,110,000 as of its most recent SEC filing.

Other institutional investors have also recently bought and sold shares of the company. Farther Finance Advisors LLC grew its holdings in HealthEquity by 232.4% during the second quarter. Farther Finance Advisors LLC now owns 246 shares of the company's stock valued at $26,000 after purchasing an additional 172 shares during the period. WPG Advisers LLC bought a new position in HealthEquity in the first quarter valued at approximately $28,000. Northwestern Mutual Wealth Management Co. lifted its stake in HealthEquity by 176.4% in the first quarter. Northwestern Mutual Wealth Management Co. now owns 655 shares of the company's stock valued at $58,000 after buying an additional 418 shares in the last quarter. Sellwood Investment Partners LLC bought a new position in HealthEquity in the second quarter valued at approximately $58,000. Finally, Larson Financial Group LLC lifted its stake in HealthEquity by 1,366.0% in the first quarter. Larson Financial Group LLC now owns 689 shares of the company's stock valued at $61,000 after buying an additional 642 shares in the last quarter. Institutional investors and hedge funds own 99.55% of the company's stock.

Analyst Upgrades and Downgrades

A number of research analysts have weighed in on the stock. Jefferies Financial Group lifted their price target on shares of HealthEquity from $130.00 to $134.00 and gave the company a "buy" rating in a research note on Wednesday, September 3rd. JPMorgan Chase & Co. lifted their price target on shares of HealthEquity from $125.00 to $126.00 and gave the company an "overweight" rating in a research note on Wednesday, September 3rd. Barrington Research reaffirmed an "outperform" rating and issued a $125.00 price target on shares of HealthEquity in a research note on Friday, August 29th. Weiss Ratings reaffirmed a "hold (c+)" rating on shares of HealthEquity in a research note on Wednesday, October 8th. Finally, Royal Bank Of Canada lifted their price target on shares of HealthEquity from $109.00 to $110.00 and gave the company an "outperform" rating in a research note on Wednesday, September 3rd. One investment analyst has rated the stock with a Strong Buy rating, eleven have given a Buy rating and two have issued a Hold rating to the company's stock. Based on data from MarketBeat.com, HealthEquity presently has an average rating of "Moderate Buy" and an average target price of $121.31.

Read Our Latest Stock Report on HQY

HealthEquity Stock Performance

Shares of HQY stock opened at $92.55 on Thursday. The company's fifty day simple moving average is $91.75 and its 200-day simple moving average is $93.94. The company has a quick ratio of 4.23, a current ratio of 4.23 and a debt-to-equity ratio of 0.47. The firm has a market cap of $7.97 billion, a PE ratio of 56.09, a P/E/G ratio of 1.35 and a beta of 0.47. HealthEquity, Inc. has a 12 month low of $74.07 and a 12 month high of $116.65.

HealthEquity (NASDAQ:HQY - Get Free Report) last announced its quarterly earnings data on Tuesday, September 2nd. The company reported $0.92 EPS for the quarter, hitting analysts' consensus estimates of $0.92. The business had revenue of $325.80 million for the quarter, compared to analyst estimates of $320.68 million. HealthEquity had a net margin of 11.49% and a return on equity of 12.04%. HealthEquity has set its FY 2026 guidance at 3.740-3.91 EPS. Equities research analysts expect that HealthEquity, Inc. will post 2.32 EPS for the current fiscal year.

Insiders Place Their Bets

In other news, EVP Delano Ladd sold 6,000 shares of the business's stock in a transaction dated Friday, September 19th. The shares were sold at an average price of $94.11, for a total transaction of $564,660.00. Following the transaction, the executive vice president directly owned 79,456 shares in the company, valued at $7,477,604.16. The trade was a 7.02% decrease in their position. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available at this link. Also, EVP Michael Henry Fiore sold 1,781 shares of the company's stock in a transaction dated Tuesday, October 7th. The shares were sold at an average price of $88.21, for a total transaction of $157,102.01. Following the completion of the sale, the executive vice president directly owned 49,795 shares in the company, valued at approximately $4,392,416.95. The trade was a 3.45% decrease in their ownership of the stock. The disclosure for this sale can be found here. Company insiders own 1.50% of the company's stock.

HealthEquity Company Profile

(Free Report)

HealthEquity, Inc provides technology-enabled services platforms to consumers and employers in the United States. The company offers cloud-based platforms for individuals to make health saving and spending decisions, pay healthcare bills, receive personalized benefit information, earn wellness incentives, grow their savings, and make investment choices; and health savings accounts.

Recommended Stories

Want to see what other hedge funds are holding HQY? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for HealthEquity, Inc. (NASDAQ:HQY - Free Report).

Institutional Ownership by Quarter for HealthEquity (NASDAQ:HQY)

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.

Should You Invest $1,000 in HealthEquity Right Now?

Before you consider HealthEquity, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and HealthEquity wasn't on the list.

While HealthEquity currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

The Next 7 Blockbuster Stocks for Growth Investors Cover

Wondering what the next stocks will be that hit it big, with solid fundamentals? Enter your email address to see which stocks MarketBeat analysts could become the next blockbuster growth stocks.

Get This Free Report
Like this article? Share it with a colleague.